Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)

Aim. To study markers of renal dysfunction in relation to the likelihood of atrial fibrillation (AF) in patients after ST-segment elevated myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).Material and methods. The study was conducted with the inclusion of 1 5...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin
Format: Article
Language:English
Published: Столичная издательская компания 2019-05-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1908
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227627386109952
author I. A. Zolotovskaya
I. L. Davydkin
D. V. Duplyakov
V. A. Kokorin
author_facet I. A. Zolotovskaya
I. L. Davydkin
D. V. Duplyakov
V. A. Kokorin
author_sort I. A. Zolotovskaya
collection DOAJ
description Aim. To study markers of renal dysfunction in relation to the likelihood of atrial fibrillation (AF) in patients after ST-segment elevated myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).Material and methods. The study was conducted with the inclusion of 1 52 patients discharged for outpatient monitoring after STEMI. There were 4 visits: V1 - inclusion visit, V2 - in 12 months, V3 - in 18 months, V4- in 24 months with determination of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP), cystatin C, erythropoietin, galectin-3, von Willebrand factor (fW), left ventricular ejection fraction. Endpoint: new cases of AF, cardioembolic stroke, deaths.Results. After 24 months 35 patients (23.0%) were diagnosed with AF, 6 of them (3.9%) - developed cardioembolic stroke. The multivariate model of risk factors for AF included indicators: cystatin C (odds ratio [OR] 1.31; 95% confidence interval [95%CI] 1.03-1.67), NT-ProBNP (OR 1.11; 95%CI 1.03-1.19), galectin-3 (OR 0.71; 95%CI 0.55-0.91), fV (OR 0.71; 95%CI 0.55-0.91).Conclusion. The prognostic significance of cystatin C in relation to the risk of AF was established, which should be considered when assessing the prognosis in patients after STEMI.
format Article
id doaj-art-0ab58e7d7af74f8fad0423e02765697f
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2019-05-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-0ab58e7d7af74f8fad0423e02765697f2025-08-23T10:00:30ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-05-0115215916510.20996/1819-6446-2019-15-2-159-1651590Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)I. A. Zolotovskaya0I. L. Davydkin1D. V. Duplyakov2V. A. Kokorin3Samara State Medical UniversitySamara State Medical UniversitySamara State Medical UniversityPirogov Russian National Research Medical UniversityAim. To study markers of renal dysfunction in relation to the likelihood of atrial fibrillation (AF) in patients after ST-segment elevated myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).Material and methods. The study was conducted with the inclusion of 1 52 patients discharged for outpatient monitoring after STEMI. There were 4 visits: V1 - inclusion visit, V2 - in 12 months, V3 - in 18 months, V4- in 24 months with determination of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP), cystatin C, erythropoietin, galectin-3, von Willebrand factor (fW), left ventricular ejection fraction. Endpoint: new cases of AF, cardioembolic stroke, deaths.Results. After 24 months 35 patients (23.0%) were diagnosed with AF, 6 of them (3.9%) - developed cardioembolic stroke. The multivariate model of risk factors for AF included indicators: cystatin C (odds ratio [OR] 1.31; 95% confidence interval [95%CI] 1.03-1.67), NT-ProBNP (OR 1.11; 95%CI 1.03-1.19), galectin-3 (OR 0.71; 95%CI 0.55-0.91), fV (OR 0.71; 95%CI 0.55-0.91).Conclusion. The prognostic significance of cystatin C in relation to the risk of AF was established, which should be considered when assessing the prognosis in patients after STEMI.https://www.rpcardio.online/jour/article/view/1908myocardial infarctionatrial fibrillationcardioembolic strokepreventionmortalitynt-probnpgalectin-3cystatin cvon willebrand factor
spellingShingle I. A. Zolotovskaya
I. L. Davydkin
D. V. Duplyakov
V. A. Kokorin
Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
Рациональная фармакотерапия в кардиологии
myocardial infarction
atrial fibrillation
cardioembolic stroke
prevention
mortality
nt-probnp
galectin-3
cystatin c
von willebrand factor
title Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
title_full Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
title_fullStr Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
title_full_unstemmed Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
title_short Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
title_sort cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute st elevated myocardial infarction observational program fakel
topic myocardial infarction
atrial fibrillation
cardioembolic stroke
prevention
mortality
nt-probnp
galectin-3
cystatin c
von willebrand factor
url https://www.rpcardio.online/jour/article/view/1908
work_keys_str_mv AT iazolotovskaya cardiorenalrelationshipsinthefocusofrisksofatrialfibrillationinpatientsafteracutestelevatedmyocardialinfarctionobservationalprogramfakel
AT ildavydkin cardiorenalrelationshipsinthefocusofrisksofatrialfibrillationinpatientsafteracutestelevatedmyocardialinfarctionobservationalprogramfakel
AT dvduplyakov cardiorenalrelationshipsinthefocusofrisksofatrialfibrillationinpatientsafteracutestelevatedmyocardialinfarctionobservationalprogramfakel
AT vakokorin cardiorenalrelationshipsinthefocusofrisksofatrialfibrillationinpatientsafteracutestelevatedmyocardialinfarctionobservationalprogramfakel